Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_462a78074895299039c34ff7a8164c79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6b9594e0fb996ebb00007350ed64a41 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18 |
filingDate |
1994-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a645277ee0039c4c00a56f9bd76bda19 |
publicationDate |
1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9511918-A1 |
titleOfInvention |
Antigen peptide compound and immunoassay method |
abstract |
A hepatitis C virus (HCV) antibody in a specimen is assayed by immunoassay utilizing a specific avidity between an antigen peptide compound having the following amino acid sequence (1) or (2) and an HCV antibody: Leu-Ser-Gly-Arg-Pro-Ala-Ile-Val-Pro-Asp-Arg-Glu-Val-Leu-Tyr-Gln-Glu-Phe-Asp-Glu (1); Val-Asn-Gln-Arg-Ala-Val-Val-Ala-Pro-Asp-Lys-Glu-Val-Leu-Tyr-Glu-Ala-Phe-Asp-Glu (2). This method permits simple and accurate identification of the serotype of a specimen while suppressing the cross reaction or a nonspecific reaction, accurate estimation of a possible therapeutic effect of interferons, and simplification of observation about the healing or the progress of treatment of hepatitis C. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7198892-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7728121-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7402315-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6881821-B2 |
priorityDate |
1993-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |